Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. OurPharma LLC
483
•OurPharma LLC•September 27, 2024

OurPharma LLC – FDA 483, Sep 27, 2024

Record Details

This FDA Form 483 details observations from an inspection of an outsourcing facility.

**Observation 1** notes the firm's failure to establish adequate written procedures for production and process controls. Specifically, the firm changed manufacturers for Fentanyl Citrate, USP (November 2023) and Morphine Sulfate, USP (February 2024), both active pharmaceutical ingredients (APIs) used in various drug products (e.g., Fentanyl Citrate and Morphine Sulfate formulations). No documentation of change control or assessment of potential impact on product quality, including test methods for assay, bioburden, sterility, and product stability, was found.

**Observation 2** identifies deficiencies in aseptic processing areas regarding HEPA-filtered air supply under positive pressure. Positive pressure was not consistently maintained between rooms of different classifications when doors were opened (e.g., between ISO 7 Ante Rooms and ISO 8 corridor, and ISO 8 corridor and unclassified Changing Room). The firm had not performed a risk assessment or smoke studies to demonstrate that lower quality air does not enter higher quality air areas.

**Observation 3** states that drug product labels from the outsourcing facility do not include information required by section 503B(a)(10)(A) of the FD&C Act.

**Observation 4** indicates that drug product containers do not include information required by section 503B(a)(10)(B

Company
OurPharma LLC
Inspection date
September 27, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Margaret M. Annes
View Company Profile

ID · 1bc5966c-c0e8-40a5-a929-937370d42b1c

Other documents for OurPharma LLC
  • 483 - 2026-08-12August 12, 2026

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore OurPharma LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.